Related by context. All words. (Click for frequent words.) 85 Nasdaq Listing Rule 83 NASDAQ Marketplace Rule 83 Nasdaq Marketplace Rule 80 Marketplace Rule 78 Marketplace Rules 74 Nasdaq Listing Rules 72 NASDAQ Listing Rules 69 Listing Rule 68 Reports Inducement Grants 67 Minimum Bid Price 66 MVPHS requirement 66 NASDAQ Hearings Panel 65 NASDAQ Minimum Bid 65 Nasdaq Minimum Bid 64 Notification Related 64 NASD Marketplace Rule 63 Price Requirement 63 MVPHS 63 Staff Determination Letter 62 NASDAQ Listing Qualification 62 Nasdaq Hearings Panel 62 MVPHS Rule 61 NASDAQ Listing 61 SEC Rule #b 61 Option Grants 61 Listing Requirement 61 Staff Deficiency Letter 60 Nasdaq Listing Requirements 60 Regains Compliance With 60 MR Civ 60 Publicly Held Shares 59 § 7B 59 NASDAQ Listing Requirements 59 Fed.R.Civ.P. 59 Regains Compliance 59 Nasdaq Notice Regarding 59 Repl. 59 Receives NASDAQ 59 Nasdaq SmallCap Market 58 La.Code Crim.P. art 58 regain compliance 58 NASDAQ SmallCap 58 Minimum Stockholders Equity 58 Ark. Sup 58 Regains NASDAQ 58 USC § #u 58 Pa.CS § 58 CFR § #.# [007] 58 Income Tax Regs 58 Listing Qualifications Panel 57 Hearings Panel 57 NYSE Arca Equities 57 Tenn. R. Civ 57 Continued Listing 57 RC #.# B [002] 57 Listing Qualifications Staff 57 Equity Incentive Plan 57 Rule #f 57 Listings Qualifications Panel 57 Deficiency Letter 57 IC § #-# 57 NASDAQ Listing Qualifications 56 CPLR § 56 Regain Compliance 56 #.# subd [004] 56 Abraxis trades 56 USC § #A 56 Fam. Code § 56 Regains Nasdaq 56 Rule #a 8 56 NYSE Rule #A.# 56 DR #.#.#R 1 56 Nasdaq Listing Qualifications 56 NASD Rule 56 Listing Compliance 56 USCA § 56 NASDAQ Deficiency Notice 56 Subsection b 56 Pa.RAP 56 MSc Qualified Person 56 CrR 56 #A.# [001] 56 Bankruptcy Code § 56 Symbol OBCI 56 CFR § #.# [004] 56 CFR #.#b 55 Evid. Code § § 55 Incentive Compensation Plan 55 symbol TSH 55 delisting proceedings 55 CICA Accounting Guideline 55 Stock Repurchase Plan 55 NYCRR #.# [003] 55 Takeovers Regulations 55 Legal #.# 55 Staff Determination 55 Scheduling Order 55 subsection b 55 Convertible Notes Due 55 Listing Standards 55 section #.#.# 55 FINRA Rule 55 § #-#.# [002] 55 TCA § #-#-# [003] 55 § #.#.# [001] 55 symbol HAWK 55 symbol POZN 55 Stock Buyback Program 55 NetLogic Microsystems Reports Inducement 55 Nasdaq Deficiency Notice 55 Listing Rule #.#.# [005] 55 OCGA § #-#-# [004] 55 USC § #a [002] 55 § #-#-#.# 55 Supp. 55 CFR #.# [005] 55 CFR § #.# [006] 54 Accounting Standard AASB 54 symbol LIME 54 Colo. Sess 54 Repurchase Program 54 symbol ABII 54 NCGS § 7B 54 Rule #b 54 Euroseas trades 54 Crim.R. 54 ticker ESEA 54 symbol LJPC 54 symbol AATI 54 Ala. R. Civ 54 § #-#-# b [003] 54 Remain Listed 54 symbol RMCF 54 Pa.CSA § 54 USC § 54 § #A.# 54 Rule #:#-# e 54 Nasdaq Listing Qualification 54 Rule #d 54 § #-#-# [002] 54 Rule #:#-# [001] 54 Pa. Code § 54 CFR § #.# [005] 54 TCA § #-#-# [001] 54 OCGA § #-#-# [007] 54 Stock Incentive Plan 54 USC #a [001] 54 Civ. Code § 54 #.# 5T 54 #g# 2 54 CrR #.# 54 non accelerated filer 54 CFR #.# [008] 54 § #-#-# [004] 54 CFR #.# d 53 IMJX 53 #.#-# [020] 53 #.# subd [003] 53 Section #.#.# [001] 53 Inducement Stock 53 Private SecuritiesLitigation Reform Act 53 CFR § #.# [008] 53 ORS #.# [001] 53 Redemption Notice 53 USC § #c 53 NJSA 2A :# 53 § #-#-# [005] 53 Inducement Awards 53 SEC Regulation SX 53 symbol ECBE 53 IRCP 53 FAR #.#-# [002] 53 Requisite Consents 53 #.# subdivision [004] 53 Nasdaq SmallCap 53 Receives Anticipated 53 § #-#-# b [001] 53 RCW #A.#.# [002] 53 Nasdaq EPCT 53 § #.# Vernon 53 Rule #h 53 Receives Notice From 53 ticker symbol AATI 53 subsection d 53 symbol MILL 53 OCGA § #-#-# [001] 53 DTR #.#.#R 53 subsections b 53 § #A [001] 53 La.Code Civ.P. art 53 MRS § 53 shares MVPHS 53 Recapitalization Agreement 53 Stock Repurchase Program 53 § #-# [004] 53 Rule #:#-# [002] 53 Form #c# 53 SmallCap Market 53 OCGA § #-#-# [003] 53 Senior Convertible Notes 53 OCGA § #-#-# [008] 53 IRC § 53 Stockholder Rights Plan 53 NCGS § #A 53 b Vernon Supp 53 Continued Listing Requirements 53 NJSA 2A #A 53 symbol WGW 53 NJRE 53 Minimum Tender 53 Ark. R. Civ 53 SEC Rule #g# 52 SECURITIES EXCHANGE ACT 52 Convertible Senior Subordinated 52 Id. § 52 DISMISSED WITH PREJUDICE 52 Statutory Basis 52 RCW #.#A.# 52 share repurchase authorizations 52 See USSG § #B#.# 52 initiate delisting 52 Issuer Amended 52 Rule #a [002] 52 Triggering Event 52 Share Repurchase Plan 52 KRS #.# [001] 52 P. #a 52 ERISA § 52 Delisting Notice 52 OCGA § #-#-# [005] 52 Late Filing 52 #.# subdivision [002] 52 InterGroup Corporation 52 captions Item 1A 52 OCGA § #-#-# [006] 52 Receives Delisting Notice 52 SEBI Guidelines 52 Nasdaq Delisting Notification 52 Minimum Tender Condition 52 La. RS #:# [003] 52 App.R. 52 symbol STN 52 Exchange accepts 52 Accounting Guideline 52 RCW #.#.# [002] 52 Glatfelter Declares Dividend 52 Receives Delisting Notification 52 symbol HBP 52 Nasdaq RPRX 52 FAS# R 52 Intercable ICH Inc. 52 NJSA 2C :5 52 ORS #B.# 52 Receives Deficiency Letter 52 Vernon Supp 52 KRS #.# [003] 52 USC § #t 52 vesting provisions 52 symbol COOL 52 CEQA Guidelines 52 CFR § #.#b 52 Shelf Registration Statement 52 Second Supplemental Indenture 52 Receives Notice Related 52 competitively procured pursuant 52 Stockholder Approval 52 symbol NSYS 52 CFR § #.# [001] 52 CFR #.# c 52 India Substantial Acquisition 52 Commencement Date 52 Indenture governing 52 GEM Listing Rules 52 symbol MVG 52 Section #.# [001] 52 Potential Delisting 52 Management Cease Trade 52 GTCB 52 CFR #.# [006] 52 § #-#.# [001] 52 Private Securities LitigationReform Act 52 Capital Disclosures 52 Legislation Reform Act 52 section #-#-# [001] 52 § #a [001] 51 symbol PTNR 51 Omnibus Incentive Plan 51 subds 51 NM SYMBOL ORBK 51 #.# subd [006] 51 Okla. Stat 51 USC § #e 51 Corporate Governance Statement 51 Convertible Subordinated Notes 51 CFR #.# [007] 51 § #a [002] 51 CPLR 51 symbol RNIN 51 Rule #e 51 RC #.# F 51 Nasdaq Listings Qualifications 51 USSG § #K#.# b 51 NJSA #A :# 51 CFR § § #.# [002] 51 SEBI Substantial Acquisition 51 delisting determination 51 Nasdaq Listings Qualification 51 Proposed Financing 51 Inducement Plan 51 ASTC Settlement Rules 51 Private Securities Litigation ReformAct 51 DR #.#.# 51 Listings Qualification Panel 51 AIM Rules 51 symbol BKBK 51 RSU Plan 51 NASDAQ Delisting 51 NJSA #:#-#.# [003] 51 NP #-# 51 Default Notice 51 Listing Requirements 51 Ark. R. Crim 51 USC #d 51 symbol ACTU 51 VTUS 51 commonstock 51 5TH CIR 51 § #.# [002] 51 Preferred Stockholders 51 EDCI Holdings 51 § #.# [004] 51 Prof. Code § 51 Nasdaq ZANE 51 Upcoming Deadline 51 Listing Deficiency 51 symbol ALIM 51 Project BioShield Act 51 CFR #.# [002] 51 Offering Memorandum dated 51 APNB 51 Newell Rubbermaid Declares Dividend 51 ticker symbol BCV 51 Default Status Reports 51 Listing Rule #.#A 51 Regarding Minimum Bid 51 symbol KEM 51 PMCS symbol 51 HNW trades 51 § #.# c 51 FAR Subpart 51 i #.# subds 51 symbol PHF 51 Xenith Bankshares 51 CFR § #.# [002] 51 Escrowed Shares 51 Receives Notification 51 NRS #A.# 51 MI #-# [001] 51 UNITED STATES SECURITIES ACT 51 adopted SFAS 51 Nasdaq Delisting 51 § #.#-# [006] 51 Kreisler Manufacturing Corporation 51 FAR #.# 51 USC § #d 51 CFR § #.# [003] 51 EVCI 51 § #C#.# 51 Subparagraph 51 symbol BAGL 51 Schedule #N 51 ticker symbol CAST 51 Financing Transactions 51 Order Granting 51 No. #R 51 symbol FPTB 51 Rule #c 51 NYCRR #.# [002] 51 ONSM 51 ZYXI 51 Financing Condition 51 La.RS #:# [003] 51 Long Term Incentive Plan 50 symbol THMD 50 Pharmachem Revised Offer 50 DSL.net s 50 Atikwa Minerals Corporation 50 FAR #.#-# Instructions 50 Offeror Representations 50 Variable Interest Entities FIN 50 Evid.R. 50 OCGA § 50 Minn. R. Civ 50 #.#-# b [001] 50 SEC Regulation FD 50 NASDAQ Stock 50 SEC Rule #a 50 #a subdivision 50 symbol KOG 50 § #.#-# [002] 50 Be Delisted From 50 ticker symbol SLXP 50 Acceptance Priority Levels 50 symbol SGLP 50 symbol URG 50 OCGA § #-#-# [002] 50 QTDP 50 Rules #b# 50 shares issuable pursuant 50 subsection c 50 disinterested shareholder 50 CFR #.# b 50 symbol SPG 50 USC § #b [001] 50 NJAC #:#-#.# 50 NOVT 50 Debt Settlement Agreements 50 Rules #A.# 50 Securities Purchase Agreement 50 symbol TNK 50 Minn. Stat 50 symbol CHCI 50 Inducement Award 50 Safe Harbor Provision 50 symbol TRE 50 symbol STEN 50 theSecurities Act 50 Convertible Unsecured Subordinated Debentures 50 SecuritiesExchange Act 50 ticker symbol ECF 50 FAS #R 50 CVM Instruction 50 Registrant 50 CLHI 50 symbol FXEN 50 subsequent amendments thereto 50 #.#-# b [002] 50 Shortfall Offer 50 Shelf Prospectus dated 50 Takeover Regulations 50 Inc. Nasdaq CVTX 50 § #.#-#.# 50 Permitted Bid provisions 50 ORS #.# [002] 50 Receives Notice Regarding 50 symbol EBTX 50 Default Announcement 50 symbol WGNB 50 hereof shall 50 OCGA § #-#-#.# 50 DTR #.#.# 50 § #-# [001] 50 Section #A.# 50 B Cumulative Convertible 50 Second Amended 50 Pen. Code § § 50 section #A.# [001] 50 Colorado Revised Statutes 50 Contingent Convertible Senior 50 CCI Pellet Agreements 50 eXegenics 50 % Convertible Subordinated 50 ASX Listing Rules 50 auditor attestation 50 § #-#-# [006] 50 No. #R Share 50 symbol TSRA 50 Restated Promissory Note 50 Nasdaq CYCC Nasdaq CYCCP 50 FAR Clause #.#-# 50 USSG § #E#.# 50 #b c 50 Private Placement Offering 50 Offering Circular dated 50 DC Code § 50 Plan Permitted Bid 50 Civ.R. 50 FAS#R 50 symbol URE 50 SECURITIES ACT RSO 50 xiv inclusive 50 symbol INSG 50 Voluntarily Delist 50 Annual Filings 50 Offerors Commercial applies 50 Senior Subordinated Convertible Notes 50 ticker symbol CFN 50 symbol IIN 50 USC § #a c 50 symbol ABBI 50 PRNewswire FirstCall CV Therapeutics 50 Base Offer Consideration 50 symbol BSFT 50 LSA CCP art 50 Cease Trade Orders 50 symbol MONI 50 Rules #a 50 subsec 49 FFDCA 49 ORS #A.# 49 Securities Purchase Agreements 49 Escrow Agreement 49 SNGX 49 Regains Full 49 applicable indentures 49 Circuit LAR 49 symbol ACTL 49 Regulatory Flexibility Act 49 SFAS #R 49 symbol SRN 49 Stantec trades 49 WORLD ENTERTAINMENT NEWS NETWORK 49 ADJUDGED 49 § #e 49 MacroChem Corporation 49 Company Prospectus dated 49 NJSA #:#-#.# [001] 49 Contingent Value Rights 49 Listings Policy 49 Neurogen stockholders 49 DSUs 49 TSX MVG 49 Employment Inducement Equity Incentive 49 Evidence Code 49 § #.# [001] 49 § #-#-# c [002] 49 symbol TLCR 49 symbol LSG 49 USC § #a [001] 49 Escrow Release Conditions 49 #A.# [005] 49 Rule #A.# 49 symbol MCRS 49 NRS #.# [001] 49 ESIO 49 See INA § 49 Doc. No. 49 Voluntary Delisting 49 Changes Ticker Symbol 49 firearm Pen. Code § 49 symbol MASC 49 § #.# [005] 49 Substantial Issuer Bid 49 La. Code Civ 49 Transmeridian Exploration Incorporated 49 please visit www.medicinova.com 49 Announces Delisting 49 section #-#-# [002] 49 symbol DIB 49 ARS § #-# [001] 49 Salix trades 49 Common Stock 49 Statement #R 49 Performance Incentive Plan 49 thePrivate Securities Litigation Reform 49 NJSA #:# C 49 DIP Financing Facility 49 Newmont Declares Regular 49 HRS § #-# [001] 49 FASB Interpretation No. 49 PrivateSecurities Litigation Reform Act 49 Registration Statement Declared Effective 49 Annual Meeting Date 49 ticker LUPE 49 AS AMENDED 49 Preferred Stock Dividend 49 Dobhai 49 ENZON 49 Required Filings 49 ticker symbol CTS 49 KSA #-# [001] 49 § #-#.# [003] 49 Basic Subscription Privilege 49 CBay Holdings 49 Unsolicited Proposal From 49 § #L#.# b 49 SCR #:#.# [002] 49 Trust Indenture 49 ticker symbol VIMC 49 END FOOTNOTE FOOTNOTE 49 stockholder approval 49 Restricted Stock 49 See USSG § #A#.# 49 ticker TSLA 49 Corporate Governance Principles 49 Form #b 49 Multilateral Instrument #-# MI# 49 USSG § #K#.# 49 See id 49 Inc. NASDAQ CVTX 49 Repurchase Offer 49 symbol FGT 49 CSR #-#.# 49 Targanta Therapeutics Corporation 49 symbol PMN 49 CFR pt 49 NFI hereafter 49 LTRX 49 KSA #-# [002] 49 symbol PEH 49 Antitrust Improvement 49 PS § 49 filed Form #b 49 CIM Mineral Exploration 49 Private Securities Reform Act 49 symbol IFNY 49 UNTK 49 USC § § 49 Stipulation 49 NASDAQ BDSI 49 Audited Financials 49 mistake inadvertence surprise 49 Non Brokered Financing 49 WpUG 49 ticker symbol DATA 49 Qualifying Transaction QT 49 symbol CLM 49 symbol RICK 49 accordance LR #.#.#R 49 Coalcorp Provides Updated 49 symbol IHP 49 MedCom USA Inc. 49 Reverse Stock 49 #A#.# 49 CICA Handbook Section 49 symbol IBNK 49 GLOBE NEWSWIRE Icagen 49 u pon 49 Superior Proposal 49 KRS #A.# [001] 49 Voluntarily Delist From 49 SFAS#R 49 Doc. # 49 NASD OTC Bulletin 49 SBLKW respectively 49 symbol ONAV 49 BUY Rating 49 Nasdaq PPCO 49 Special Stockholder Meeting 49 Supplement dated 49 NYSE CXS 49 Make Normal Course 49 Act PDUFA guidelines 49 Government Qualifying Therapeutic 49 repurchase authorizations 49 § 8C 49 Rev. Proc 49 Xebec trades 49 UGNE 49 TSX VENTURE DMA 49 R. #:#-# 49 Regulation G 48 Nasdaq CAMT 48 INA § 48 Commence Trading 48 symbol NVN 48 Rules #b 48 NJSA 2C :2 48 § #-#-# g 48 TriPath Oncology 48 Definitive Merger Agreement 48 GL c 48 USSG § #L#.# b 48 Nasdaq SVNT 48 Qualified Therapeutic Discovery 48 DEFINITIONS 48 TXIC 48 NYSE PHH PHH 48 TayCon Capital Corporation 48 Inc. NASDAQ ONTY 48 USC § #a b 48 STOCK BASED COMPENSATION 48 trading symbol GCKO 48 #.# subds [002] 48 Increases Share Repurchase 48 ASX Corporate Governance 48 FASB Statement 48 Code § #.#-# [001] 48 Ampio Pharmaceuticals Inc. 48 PRAECIS PHARMACEUTICALS INCORPORATED 48 DTR #.#.# b 48 Immediate Effectiveness 48 Listing Qualifications 48 § #-#-# [003] 48 Multilateral Instrument 48 Shelf Registration 48 symbol CYTC 48 Concurrent Financing 48 Evid. Code § 48 Convertible Notes tendered 48 symbol XBC 48 symbol LPTH 48 NCGS § 48 symbol PCCD 48 ARF.UN symbol 48 symbol STLY 48 Discovery Project QTDP 48 Actof 48 Aumento 48 SECURITIES ACT OF 48 SECTION #E OF 48 ITWO 48 AEDPA 48 § #-#-# [001] 48 § #.#-# [001] 48 FedFirst Financial Corporation 48 Indentures governing 48 proprietary Capillary Aerosolization Technology 48 symbol VRNT 48 Payment SFAS #R 48 adopted SFAS #R 48 symbol SWY 48 COGE Handbook 48 Explores Strategic Alternatives 48 Civil Code § 48 § #b [001] 48 symbol GGP 48 Contingent Convertible Notes 48 NQCI 48 Derivative Action 48 symbol DGLY 48 TCA § 48 endedDecember 48 WpHG mit dem Ziel 48 Articles Supplementary 48 Seek Shareholder Approval 48 CICA Handbook section 48 Extends Tender Offer 48 symbol AMFI 48 symbol STE 48 Incentive Plan 48 NASDAQ 48 DGCL 48 Shareholder Approval 48 symbol XDC 48 KRS #.# [002] 48 Announce Early Termination 48 Antler Creek Shares 48 symbol AVXL 48 Noront Offer 48 Rule #:#-# b 48 symbol CRK 48 Avigen stockholders 48 Stapling applies 48 § #.# b 48 NRS #.# [002] 48 Acquisition Proposal 48 Capitalised terms used 48 developing biomedical countermeasures 48 NASDAQ NOVN 48 Files Shelf Registration Statement 48 NeuroMedix 48 trading symbol TEZ 48 Vesting Date 48 NJSA #:#-# [001] 48 See USSG § #D#.# 48 Polydex Pharmaceuticals Limited 48 Supplemental Indenture 48 PPBV 48 hereby ORDERED ADJUDGED 48 Anders v. 48 Exclusivity Period 48 § #.#-# [004] 48 Convertible Subordinated Debentures 48 § #A [003] 48 symbol LDSH 48 Supplemental Indentures 48 Incentive Stock 48 MDIN 48 symbol ABCW 48 symbol HBNC 48 Maximum Aggregate 48 Public Contracts Regulations 48 Common Stock Repurchase 48 Euronext Paris ticker ALEHT 48 Multilateral Instrument #-# 48 symbol MAGS 48 Purchase Warrants 48 KRONOS WORLDWIDE 48 AVANT Immunotherapeutics Inc. 48 Restated Declaration 48 Tennessee Code Annotated 48 Metabasis stockholders 48 TCA #-#-# [003] 48 TRUSTCASH 48 Listing Rule #.#.# [004] 48 Original Bidder Statement 48 Nasdaq OMX Stockholm 48 Cygne Designs Inc. 48 CFR § § #.# [001] 48 symbol LSTR 48 OSC Policy 48 subparagraph 48 Units RSUs 48 Receives Notification From 48 Annual Required Filings 48 See TCA § 48 symbol IBKC 48 USCS § 48 Employment Inducement Awards 48 Eligibility Liability Release 48 symbol TOL 48 § § #.# [002] 48 TSX PFB 48 MZT Holdings 48 Technology NASDAQ WATG 48 Debenture Holder 48 symbol KAB 48 symbol APIO 48 Symbol RXE 48 Genta Incorporated OTCBB GNTA.OB 48 Id. ¶ 48 symbol MSTR 48 cusip number 48 meaning ascribed thereto 48 Packeteer Form 48 Restated Bylaws 48 Merger Transaction 48 § #B#.# [001] 48 Default Status Report 48 symbol FFN 48 Onsino 48 Fero Industries Inc. 48 Vishay stockholders 48 Complete EHRs 48 Symbol Change 48 USC § § #e 48 Merger Agreement 48 Secured Debenture 48 Sunridge trades 48 Exchange Act 48 Minimum Condition 48 Proposed Transactions 48 Immtech clinical trials 48 Thoma Bravo Merger 48 Dreyfus Strategic Municipals 48 TASE EVGN.TA 48 NJSA 2C :# 2a 48 Required Documents 48 TSX VENTURE VRW 48 PRNewswire FirstCall Neose Technologies 48 SFAS #R Share 48 Nasdaq WCRX 48 Convertible Debenture Financing 48 #d# [001] 48 Disclaimer c 48 Forbearance Agreement 48 RMX TSX 48 DREAMS INC. trades 48 Zero Coupon Convertible Debentures 48 lender consents 48 General Statutes § 48 scienter requirement 48 Official Quotation 48 NYSE AMEX XNN 48 OncoGenex Pharmaceutical 48 QMNM 48 OF WARRANTS 48 UBS AG Bahnhofstrasse 48 Act ERISA Breach 48 Pen. Code § #.# [001] 48 Sepia imprint 48 symbol PAYD 48 applicable Offering Memorandum 48 SEBI SAST Regulations 48 See OCGA § 48 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 48 Overallotment Option 48 Defined Terms 47 NASDAQ BASI 47 NJSA #:#-# [002] 47 ARS § #-#.# 47 FSP FAS #-# 47 Aradigm Corporation OTCBB ARDM 47 QDHC 47 Comamtech 47 CIM Guidelines 47 SEBI ICDR Regulations 47 RC #.# [002] 47 Secured Convertible Debentures 47 unexercised warrants 47 § #A [002] 47 CUSIP Number 47 symbol TTHI 47 DIP financing facility 47 RCr 47 Warrant Term 47 trading symbol FFIN 47 symbol CDXS 47 NeoRx Corporation 47 Amending Agreement 47 Complete Response letter 47 Precision Optics Corporation 47 Relevant Period 47 symbol AGXM 47 USC § #a [003] 47 ticker ORL 47 section #AA 47 vphl Norwegian Securities 47 symbol INKS 47 IBNW 47 Based Payment SFAS 47 Resale Registration Statement 47 CICA Handbook 47 adopted CICA Handbook 47 ticker symbol EFSI 47 IIROC Dealer Member 47 PRNewswire FirstCall Pharmos 47 XenoPort NASDAQ XNPT 47 Inducement Grant 47 evaluating intravenous picoplatin 47 Inc. NASDAQ ZLCS 47 HSR Act 47 symbol PXS 47 ticker symbol AFR 47 Exchangeco 47 CTNXF 47 optionee 47 TSX VENTURE CHQ 47 NYSE KV.A 47 NASDAQ XTLB 47 CYIO 47 Defendants misrepresented 47 discloseable transaction 47 ARS § 47 SPECIAL BUSINESS 47 symbol MERU 47 ticker symbol AXA 47 IT IS ORDERED 47 ticker symbol OPERA 47 Going Concern Qualification 47 ticker symbol LAVA 47 HSR Waiting Period 47 symbol SWS 47 Silvercorp Offer 47 J Antimicrob Chemother 47 symbol LRI 47 La.Civ.Code art 47 vacatur 47 NASDAQ CPEX 47 Rule #b# 47 Junior Subordinated Notes 47 FASB Interpretation 47 c Copyright Thomson Reuters 47 #,#,# warrants exercisable 47 Fiduciary Duties 47 Amended Judgment 47 FINANCIAL PROMOTION ORDER 47 FAR clauses 47 Amends Tender Offer 47 Rule #b 5 47 Initial Purchasers 47 symbol SPPN 47 symbol OTCBB EVSI 47 Reproduced Record RR 47 Amex DEJ TSX Venture 47 SECURITIES AND EXCHANGE ACT 47 Hurasu Resource Corporation 47 TSX RVX 47 USC § #b [002] 47 ticker symbol GLP 47 Merger Agreement dated 47 symbol LOR 47 p rior 47 Interim Filings 47 materiality threshold 47 Eurogas Corporation 47 Accelerated Share Repurchase 47 FSP EITF #-#-# [001] 47 USSG § #L#.# 47 Form #Q filed 47 Waiver Agreement 47 Civil Procedure Rule 47 Camtek Ltd. NASDAQ 47 AS #.#.# 47 DIP Loan 47 Avanir Pharma 47 HRS § #-# [002] 47 Veh. Code § 47 RC #.# B [001] 47 adopted FASB Interpretation 47 ticker symbol CNVR 47 Share Repurchase 47 SFAS No. 47 constituteforward looking 47 BMNM 47 Nasdaq CYCCP Cyclacel 47 Nasdaq THMD 47 Proposed Arrangement 47 Receives ONC ATCB 47 MHPAEA 47 ITEX undertakes 47 H Quotient 47 hereinafter defined 47 Ohr Pharmaceutical Inc. 47 USSG § 47 Proposed Rule Change 47 La. RS #:# [001] 47 symbols CRDA